News
Global Cannabis News & Analysis | Business of Cannabis
News · page 61
- Pharmaceutical
High-Profile Director Quits Oxford Cannabinoid Technologies Board Following Chairman’s Recent Departure
Oxford Cannabinoid Technologies (OCT) has seen its second senior departure in under a month as it begins to recover from the fallout of a credit deal which breached market rules.
- Pharmaceutical
Work To Start On UK Mainland’s First Commercial Cannabis Cultivation Facility For Over 20 Years
GLASS Pharms has agreed a £22.5m funding deal to build the UK mainland’s first, high-THC, commercial cultivation facility for over 20 years.
- CBD Market
Waitrose to stock Cannaray CBD Gummies
Cannaray has announced a partnership with Waitrose and Partners which will see them supply the chain’s 250 stores across the UK.
- Medical
Groups From 56 Countries Ask UN To Ensure Secretive ‘Cannabis Initiative’ Is Open To Public Scrutiny
ONE year on from the formal recognition of the potential for cannabis as a medicine almost 200 global advocacy and civil society groups are backing for calls for greater transparency over emerging new cannabis guidelines.
- News
Helping Create ‘A Loud, Proud, Clean, Transparent, Open, Thoughtful, And Considerate Cannabis Industry’
Writing for BusinessCann Toby Shillito, Chair of the Cannabis Industry Council’s Environmental & Social Responsibility Subgroup, elaborates on the importance of corporate responsibility in an industry ‘born with reputational issues’.
- Markets & Stocks
MGC Pharmaceuticals Tells Shareholders Pending Deal Could ‘Transform Finances Overnight’
MGC Pharmaceuticals told shareholders attending its Annual General Meeting (AGM) that it is on track to deliver ‘far and away the best financial performance of the company’ in the coming months.
- CBD Market
Yooma Aiming For Annual Revenues Of $20m-Plus With Buying Spree Set To Continue
YOOMA Wellness saw revenues decline in its third quarter but managed to taper losses as it continued to buy up international CBD and wellness brands at pace.
- News
French Biotech Start-up Secures Country’s First Medical Cannabis Research Licence
Biotech start-up Overseed has been awarded the first licence for agronomic and genetic research on cannabis in France by the National Agency for the Safety of Medicines and Health Products (ANSM).
- CBD Market
‘Flawed’ CBD Safety Advice Costs Industry Millions of Pounds In ‘Unnecessary’ Animal Tests
THE CBD industry is being failed by ‘unnecessary’ ‘unethical’ and ‘unscientific’ directions from the UK regulators, claim the authors of a new report.
- News
Former Prime Minister’s Cannabis Company Delivers 170% Sales Boost
INTERCURE is predicting revenues of C$100m (£59m) over the coming year after reporting record sales in its third quarter.
- Adult-Use
What Must Be Done To Enact Germany’s New Cannabis Law And What Will Its Adult-Use Market Look Like?
With Germany’s Government-in-waiting set to deliver adult-use cannabis, BusinessCann explores the delivery challenges and how the legislation may be shaped.
- Cultivation
Guernsey Issues Its First Medical Cannabis Cultivation Licence To 4C Labs With More Set To Follow
4C LABS has become the first and only company to be awarded a medical cannabis cultivation licence in Guernsey marking a major milestone for the Channel Islands’ cannabis industry.
